PPARD and Insulin resistance: Since PPARδ activators have been shown to improve insulin resistance and reduce plasma glucose in rodent models of type 2 diabetes and reduce serum triglycerides in sedentary human [21], [22], we aimed to test whether AI extracts have the ability to activate PPARδ as a potential mechanism of action in mediating its beneficial effects.